Sanuwave Health Revenue 2010-2024 | SNWVD
Sanuwave Health revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Sanuwave Health Annual Revenue
(Millions of US $) |
| 2023 |
$20 |
| 2022 |
$17 |
| 2021 |
$13 |
| 2020 |
$4 |
| 2019 |
$1 |
| 2018 |
$2 |
| 2017 |
$1 |
| 2016 |
$1 |
| 2015 |
$1 |
| 2014 |
$1 |
| 2013 |
$1 |
| 2012 |
$1 |
| 2011 |
$1 |
| 2010 |
$1 |
| 2009 |
$1 |
Sanuwave Health Quarterly Revenue
(Millions of US $) |
| 2024-06-30 |
$7 |
| 2024-03-31 |
$6 |
| 2023-12-31 |
$7 |
| 2023-09-30 |
$5 |
| 2023-06-30 |
$5 |
| 2023-03-31 |
$4 |
| 2022-12-31 |
$5 |
| 2022-09-30 |
$4 |
| 2022-06-30 |
$4 |
| 2022-03-31 |
$3 |
| 2021-12-31 |
$4 |
| 2021-09-30 |
$4 |
| 2021-06-30 |
$3 |
| 2021-03-31 |
$2 |
| 2020-12-31 |
$2 |
| 2020-09-30 |
$1 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$0 |
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
$0 |
| 2018-12-31 |
$0 |
| 2018-09-30 |
$1 |
| 2018-06-30 |
$0 |
| 2018-03-31 |
$0 |
| 2017-12-31 |
$0 |
| 2017-09-30 |
$0 |
| 2017-06-30 |
$0 |
| 2017-03-31 |
$0 |
| 2016-12-31 |
$1 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$0 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
$0 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$0 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
$0 |
| 2012-09-30 |
$0 |
| 2012-06-30 |
$0 |
| 2012-03-31 |
$0 |
| 2011-12-31 |
$0 |
| 2011-09-30 |
$0 |
| 2011-06-30 |
$0 |
| 2011-03-31 |
$0 |
| 2010-12-31 |
$0 |
| 2010-09-30 |
$0 |
| 2010-06-30 |
$0 |
| 2010-03-31 |
$0 |
| 2009-12-31 |
$0 |
| 2009-09-30 |
$0 |
| 2009-06-30 |
$0 |
| 2009-03-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.056B |
$0.020B |
|
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
|
